NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 174192 | RG7800 ( RO6885247 ) | 1449598-06-4 | ≧98.0% |  |
| RG7800(RO6885247) is a small molecule modifier of survival motor neuron 2 splicing. | ||||
| 178017 | Isosulfan blue | 68238-36-8 | ≧98.0% |  |
| Isosulfan blue is a synthetic visual lymphatic imaging agent. Injected into the perip | ||||
| 90734 | RSM932A | 850807-63-5 | ≧98.0% | .png) |
| Choline kinase α (CHKA; here designated as ChoKα) is the first enzyme in the CDP-ch | ||||
| 184321 | Ensartinib ( X396 ) | 1370651-20-9 | >98% |  |
| Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine k | ||||
| 185235 | Trilaciclib (G1T28) | 1374743-00-6 | >98% |  |
| TRILACICLIB (G1T28), A HIGHLY POTENT, TRANSIENT CDK 4/6 INHIBITOR WITHIC50s OF 1 nM A | ||||
| 185253 | ARV-825 | 1818885-28-7 | >98% |  |
| ARV-825 is a PROTAC (proteolysis-targeting chimera). ARV-825 exerts superior lethal a | ||||
| 188281 | Arimoclomol maleate | 289893-26-1 | 98% |  |
| Arimoclomol, also known as BRX-220, is potentially useful for the treatment of Nieman | ||||
| 1811162 | PF-05231023 | 1037589-69-7 | >98% |  |
| PF-05231023 is a long-acting FGF21 mimetic. PF-05231023 decreases body weight and imp | ||||
| 1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% | _1360460-82-7.png) |
| Anlotinib is a novel oral tyrosine kinase inhibitor (TKI) targeting c-kit, platelet-d | ||||
| 191122 | Tafenoquine ( WR 238605 ) | 106635-80-7 | ≧98.0% |  |
| Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||
| S510901 | Cenicriviroc Mesylate | 497223-28-6 | 98% Min. |  |
| Cenicriviroc (CVC) is an oral, once-daily, potent immunomodulator that blocks two che | ||||
| 512193 | ITI-214(phosphate) | 1642303-38-5 | 98% Min. |  |
| ITI-214 is a potent and selective phosphodiesterase 1 (PDE1) inhibitor. As the clinic | ||||